Publications | Lund University Publications

1 – 7 of 7

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author%3D%22Sihto%2C+Harri%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor%3D%22Sihto%2C+Harri%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2022
Mark Fibrinogen-like protein 2 in gastrointestinal stromal tumour
Pulkka, Olli Pekka ; Viisanen, Leevi ; Tynninen, Olli ; Laaksonen, Maria ; Reichardt, Peter ; Reichardt, Annette ; Eriksson, Mikael ^LU ; Hall, Kirsten Sundby ; Wardelmann, Eva and Nilsson, Bengt , et al. (2022) In Journal of Cellular and Molecular Medicine 26(4). p.1083-1094
- Contribution to journal › Article
2018
Mark Expression of cell cycle regulators and frequency of TP53 mutations in high risk gastrointestinal stromal tumors prior to adjuvant imatinib treatment
Ihle, Michaela Angelika ; Huss, Sebastian ; Jeske, Wiebke ; Hartmann, Wolfgang ; Merkelbach-Bruse, Sabine ; Schildhaus, Hans Ulrich ; Büttner, Reinhard ; Sihto, Harri ; Hall, Kirsten Sundby and Eriksson, Mikael ^LU , et al. (2018) In PLoS ONE 13(2).
- Contribution to journal › Article
2017
Mark SLUG transcription factor : A pro-survival and prognostic factor in gastrointestinal stromal tumour
Pulkka, Olli Pekka ; Nilsson, Bengt ; Sarlomo-Rikala, Maarit ; Reichardt, Peter ; Eriksson, Mikael ^LU ; Hall, Kirsten Sundby ; Wardelmann, Eva ; Vehtari, Aki ; Joensuu, Heikki and Sihto, Harri (2017) In British Journal of Cancer 116(9). p.1195-1202
- Contribution to journal › Article
Mark Effect of KIT and PDGFRA mutations on survival in patients with gastrointestinal stromal tumors treated with adjuvant imatinib : An exploratory analysis of a randomized clinical trial
Joensuu, Heikki ; Wardelmann, Eva ; Sihto, Harri ; Eriksson, Mikael ^LU ; Sundby Hall, Kirsten ; Reichardt, Annette ; Hartmann, Jörg T ; Pink, Daniel ; Cameron, Silke and Hohenberger, Peter , et al. (2017) In JAMA Oncology 3(5). p.602-609
- Contribution to journal › Article
2016
Mark Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial.
Joensuu, Heikki ; Eriksson, Mikael ^LU ; Sundby Hall, Kirsten ; Reichardt, Annette ; Hartmann, Jörg T ; Pink, Daniel ; Ramadori, Giuliano ; Hohenberger, Peter ; Al-Batran, Salah-Eddin and Schlemmer, Marcus , et al. (2016) In Journal of Clinical Oncology 34(3). p.244-250
- Contribution to journal › Article
2014
Mark Risk Factors for Gastrointestinal Stromal Tumor Recurrence in Patients Treated With Adjuvant Imatinib
Joensuu, Heikki ; Eriksson, Mikael ^LU ; Hall, Kirsten Sundby ; Hartmann, Joerg T. ; Pink, Daniel ; Schuette, Jochen ; Ramadori, Giuliano ; Hohenberger, Peter ; Duyster, Justus and Al-Batran, Salah-Eddin , et al. (2014) In Cancer 120(15). p.2325-2333
- Contribution to journal › Article
2012
Mark One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor : A Randomized Trial
Joensuu, Heikki ; Eriksson, Mikael ^LU ; Hall, Kirsten Sundby ; Hartmann, Joerg T. ; Pink, Daniel ; Schuette, Jochen ; Ramadori, Giuliano ; Hohenberger, Peter ; Duyster, Justus and Al-Batran, Salah-Eddin , et al. (2012) In JAMA: The Journal of the American Medical Association 307(12). p.1265-1272
- Contribution to journal › Article